During the past decade, Saskatoon Medical Specialists conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Saskatoon Medical Specialists" are "Crohn's Disease" (2 trials), "Atherosclerosis" (1 trials), "Atrial Fibrillation" (1 trials), "Coronary Artery Disease" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Saskatoon Medical Specialists" in a lesser frequency.

Most popular intervention types in "Saskatoon Medical Specialists" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "AGI-1067" (1 trials), "Dehydroepiandrosterone [DHEA]" (1 trials), "SR34006 (idraparinux sodium) Injection" (1 trials), "STA-5326 mesylate" (1 trials) and "vitamin K antagonist (warfarin or acenocoumarol) tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saskatoon Medical Specialists" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Saskatoon Medical Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Saskatoon Medical Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saskatoon Medical Specialists, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".